| |
|
|
|
Derycz Scientific  
|
|
2.08 0.06 (0.03%) |
03-01 16:00 |
|
Open: |
2.06 |
Pre close: |
2.02 |
Target:
|
2.89
|
|
High: |
2.1 |
Low: |
2.04 |
Resistance:
|
2.48
2.77
|
|
Volume: |
127,713 |
Market Cap: |
55M |
Support:
|
2.00
1.66
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.11
 |
MACD |
MACD(12,26):
|
-0.10 |
|
MA(20): |
2.38 |
Signal(12,26,9): |
-0.05 |
|
MA(100): |
2.35 |
Stochastic Oscillator |
%K(14,3):
|
8.48  |
|
MA(250): |
2.56 |
%D(3): |
9.83 |
|
Average Volume(K) |
3-Month: |
25564
|
52-Week |
High:
|
3.50 |
|
10-Days: |
17595 |
Low: |
2.00 |
|
RSI |
RSI(14):
|
34.55 |
Change(%): |
-37.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.022 |
Return on Equity (ttm) |
-16.4 |
Shares Out. (M) |
26.26 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-3.3 |
Shares Float (M) |
9.05 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
31.57 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
2.0 |
% Held by Institutions |
46.02 |
|
Forward EPS |
-0.040 |
Gross Profit (p.s.) |
0.367 |
Shares Short (K) |
39 |
|
Book Value (p.s.) |
0.190 |
EBITDA (p.s.) |
-0.026 |
P/E |
-94.55 |
|
Sales Per Share |
1.188 |
Qtrly Earnings Growth |
0.00 |
P/BV |
10.95 |
|
Profit Margin |
-1.81 |
Operating Cash Flow
(M) |
3.03 |
P/S |
1.75 |
|
Operating Margin |
-2.27 |
Levered Free Cash Flow
(M) |
3.27 |
P/CF |
18.03 |
|
|
|
|
|
|
